← Leaderboards
Aaron M. Mohs
Emory University
$6,417,670
Attributed
$8,072,291
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,072,291 · 7
By mechanism
R01$6,581,676 · 4
R00$707,892 · 1
R21$596,356 · 1
K99$186,367 · 1
Top collaborators
- Sarah A Holstein5 shared
- David F Wiemer5 shared
Most similar at Emory University
Same institution · by research overlap
- John S. Lollar$19,901,192
- Douglas C Eaton$36,075,657
- Lou Ann S. Brown$18,575,356
- I Marc Moss$3,499,158
- Jesse Roman-Rodriguez$12,571,619
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorDesignMalignant NeoplasmsPropertyFluorescenceFluorophoreDrug KineticsBaseOpticsMalignant - DescriptorPolymersCellsNanoparticleFluorescent DyesDetectionImageContrast MediaInnovationIn VivoIn VitroLeadMorbidity - Disease RateBiodistributionAntibodies
Grant awards (26)
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$503,088
R01 · FY2025 · CA
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer$356,318
R01 · FY2025 · CA · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$477,934
R01 · FY2024 · CA
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer$338,504
R01 · FY2024 · CA · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$493,027
R01 · FY2023 · CA
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer$349,192
R01 · FY2023 · CA · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$492,732
R01 · FY2022 · CA
Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer$365,076
R01 · FY2022 · CA · contact PI
A ratiometric fluorescent sensor array for bacterial pathogen investigation$343,125
R01 · FY2022 · EB · contact PI
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$515,150
R01 · FY2021 · CA
A ratiometric fluorescent sensor array for bacterial pathogen investigation$336,262
R01 · FY2021 · EB · contact PI
A ratiometric fluorescent sensor array for bacterial pathogen investigation$343,125
R01 · FY2020 · EB · contact PI
A ratiometric fluorescent sensor array for bacterial pathogen investigation$343,125
R01 · FY2019 · EB · contact PI
Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications$182,481
R21 · FY2019 · CA · contact PI
Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications$188,125
R21 · FY2018 · CA · contact PI
Hyaluronic Acid Based Nanoparticles for Targeted Image-Guided Tumor Surgery$326,004
R01 · FY2017 · EB · contact PI
Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications$225,750
R21 · FY2017 · CA · contact PI
Hyaluronic Acid Based Nanoparticles for Targeted Image-Guided Tumor Surgery$326,008
R01 · FY2016 · EB · contact PI
Hyaluronic Acid Based Nanoparticles for Targeted Image-Guided Tumor Surgery$331,852
R01 · FY2015 · EB · contact PI
Hyaluronic Acid Based Nanoparticles for Targeted Image-Guided Tumor Surgery$341,154
R01 · FY2014 · EB · contact PI
Nanotechnology for Minimally Invasive Cancer Detection and Resection$154,584
R00 · FY2014 · CA · contact PI
Nanotechnology for Minimally Invasive Cancer Detection and Resection$76,173
R00 · FY2014 · CA · contact PI
Nanotechnology for Minimally Invasive Cancer Detection and Resection$228,192
R00 · FY2013 · CA · contact PI
Nanotechnology for Minimally Invasive Cancer Detection and Resection$248,943
R00 · FY2012 · CA · contact PI
Nanotechnology for Minimally Invasive Cancer Detection and Resection$94,106
K99 · FY2011 · CA · contact PI
Nanotechnology for Minimally Invasive Cancer Detection and Resection$92,261
K99 · FY2010 · CA · contact PI